论文部分内容阅读
目的 :探讨中药复方制剂参桃软肝丸治疗实验性肝癌的药效和机理。方法 :建立荷肝癌 (H2 2 )小鼠模型 ,观察参桃软肝丸对其肿瘤生长和IL -2、NK细胞活性的影响。结果与结论 :参桃软肝丸能显著抑制肿瘤的生长 ,大剂量的抑瘤率达 4 6.8% ,并可明显提高荷肝癌小鼠的免疫功能。
Objective: To explore the efficacy and mechanism of Shentao Ruangan Pills for treatment of experimental liver cancer. METHODS: A mouse model of liver cancer (H2 2) was established to observe the effects of Shentao Ruangan Pill on its tumor growth and the activity of IL-2 and NK cells. RESULTS AND CONCLUSION: Shentao Ruangan Pills can significantly inhibit the growth of tumors, and the high-dose rate of tumor inhibition reached 46.8 percent, and can significantly improve the immune function of hepatoma-bearing mice.